Skip to main content

Surface Oncology, Inc.

SURFDelisted Sep 8, 2023
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001718108

Surface Oncology, Inc. was delisted on Sep 8, 2023; its insiders filed their last Form 4 on Sep 8, 2023; 62 institutions reported holding it in 13F filings for Q2 2023, worth $16.9M in total; ARK Invest was the only superinvestor holding it.

Q3 2021 vs. Q2 2021

How the institutions holding Surface Oncology, Inc. changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of SURF: Q2 2021 compared with Q3 2021
MeasureQ2 2021Q3 2021Change
Holders9792−5
Shares22.6M24.1M+1.48M (+6.6%)
Value$168.5M$182.2M+$13.7M (+8.1%)

New holders (17)

Institutions that held Surface Oncology, Inc. at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to SURF in Q3 2021
InstitutionSharesValue% of portfolio
OrbiMed Advisors LLC909,666$6.89M0.08%
Marshall Wace, LLP232,162$1.76M0.01%
SummerHaven Investment Management, LLC128,078$970.0K0.57%
Los Angeles Capital Management LLC97,930$741.0K0.00%
Millennium Management LLC74,604$565.0K0.00%
Connor, Clark & Lunn Investment Management Ltd.43,300$328.0K0.00%
Marshall Wace North America L.P.37,784$286.0K0.00%
SG Americas Securities, LLC29,036$220.0K0.00%
LPL Financial LLC26,650$202.0K0.00%
Manufacturers Life Insurance Company, The21,704$164.0K0.00%
NinePointTwo Capital16,206$122.0K0.05%
Schonfeld Strategic Advisors LLC14,700$112.0K0.00%
HighVista Strategies LLC13,932$105.0K0.07%
Parametric Portfolio Associates LLC12,618$96.0K0.00%
Lazard Asset Management LLC10,822$81.0K0.00%
Antonetti Capital Management LLC1,500$11.0K0.01%
Total Clarity Wealth Management, Inc.750$6.00K0.00%

Sold out (22)

Institutions that held Surface Oncology, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.